CNO Financial Group, Inc. (CNO) Income Statement

The acceleration in revenue growth, from 2.5% in 2026Q1 to 11.6% in 2026Q2, indicates that the captive agent model is gaining traction, likely driven by increased Medicare Supplement sales and annuity demand. However, the flat revenue in 2025Q1 (-12.9%) highlights volatility, possibly due to seasonal or policy changes. The sustained sales streak suggests that the distribution strategy is compounding, though investors should monitor whether this growth is translating into profitable new business.

The combined ratio has been volatile, ranging from 80.8% in 2024Q4 to 99.0% in 2024Q3, but the recent trend shows improvement, with 2026Q2 at 87.6%. This suggests that loss ratios are being managed effectively, possibly due to better morbidity assumptions or rate increases on legacy blocks. The operating margin of 6.54% is below peers like Globe Life (24.4%), but the recent EPS growth of 49.4% year-over-year indicates that margin expansion is a key driver, likely from improved investment spreads and expense control.

The significant beat in 2026Q2, with operating EPS of $1.26 versus consensus of $1.06, suggests that reserve releases or favorable development may have inflated earnings. The loss ratio of 56.6% in 2026Q2 is lower than the 61.1% in 2025Q2, indicating possible favorable claims experience. However, investors should be cautious: if reserve releases are not sustainable, future earnings could normalize. The company's legacy LTC block remains a source of uncertainty, and any adverse development could reverse these gains.

While investment income is not disclosed in the provided data, the higher-for-longer rate environment is expected to enhance yields on new investments, widening the spread between earned yields and credited rates. This is particularly beneficial for annuity and universal life products. The 45% year-over-year growth in operating EPS in 2026Q2, despite flat revenue growth, suggests that investment income is a key driver. However, if rates decline, this tailwind could reverse, pressuring margins.

The expense ratio, calculated as combined ratio minus loss ratio, has been volatile but shows a downward trend in recent quarters. This suggests that CNO is achieving better cost efficiency, possibly through technology investments or agent productivity gains. However, the high variable cost structure, with commissions and policyholder benefits, remains a drag. The company's pivot to fee-based advisory services may further improve the expense ratio over time, but execution risk remains.